[MEN] Could a Simple Saliva Test Save Your Life?

It starts with a simple swab of your cheek…

Not bloodwork. Not a biopsy. Just a saliva test.

That’s all it took for researchers to uncover a hidden danger in hundreds of older men—one that traditional screening methods would have missed entirely.

If you’re a man over 60, listen closely.

Because this new research could change how we detect—and beat—one of the deadliest cancers facing older men today: prostate cancer.

For years, the PSA (prostate-specific antigen) test has been the go-to method for early prostate cancer detection.

But here’s the problem: PSA tests are notorious for false positives, false negatives, and missed diagnoses.

They can lead to unnecessary biopsies, or worse, missed chances to catch aggressive cancer early.

Now, researchers have found a better way.

In a major study published in the New England Journal of Medicine, scientists used polygenic risk scores—a type of genetic screening that looks at your DNA (from a simple saliva sample!)—to identify men at high risk for developing prostate cancer.

And the results were nothing short of eye-opening.

Out of over 6,000 men ages 55–69 who had their polygenic risk scores analyzed, the top 10%—those with the highest genetic risk—were invited for further screening using advanced MRI and biopsies.

Here’s what they found:

• 40% of these high-risk men had prostate cancer.
• More than half of these cases were intermediate to high-risk cancers that required treatment.
• And nearly 3 out of 4 of those cases would’ve been missed by the standard PSA test alone.

That’s the game-changer.

This wasn’t a hypothetical study in a lab. These were real men, many of them in their 60s, with real cancers—cancers that were found before symptoms appeared, before the window for intervention closed.

If you’re a senior man, this study sends a clear message: Your risk for prostate cancer might not show up on a PSA test. But it could be written in your DNA.

And while polygenic testing isn’t yet routine, this research makes a strong case for including it in future screening guidelines.

But let’s be clear: this isn’t about jumping into another Big Pharma testing fad.

This is about knowing your risk—and taking action while you still have time.

Because the truth is, when prostate cancer is caught early, it’s often treatable. When it’s not… the odds shift dramatically.

While widespread polygenic risk scoring may still be on the horizon, there are smart, natural steps you can take today to support prostate health and stay ahead of this disease:

• Eat more cruciferous vegetables like broccoli and cauliflower. These contain compounds that support hormone balance and detox pathways.
• Reduce sugar and processed foods, which fuel inflammation and hormone disruption.
• Support prostate health naturally with nutrients like zinc, selenium, and saw palmetto.
• Stay active. Even a 30-minute walk can help lower your cancer risk.
• Talk to your doctor—especially if you have a family history of prostate cancer.

In the end, this new approach to prostate cancer screening—based on DNA, not just PSA—could help men catch serious disease earlier, especially those at high genetic risk who might otherwise fall through the cracks of traditional testing.

But that doesn’t mean DNA testing is right for everyone. Letting companies like 23andMe or others store and analyze your genetic data comes with its own set of risks—especially when it comes to privacy and how that information might be used or shared in the future.

If you have a family history of prostate cancer, are experiencing symptoms, or have received unclear PSA results, this type of DNA-based screening may be worth discussing with your doctor.

Otherwise, proceed with caution—because once your genetic information is out there, there’s no getting it back.

To knowing your risks,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team